Quest Diagnostics
DGX and Genomic Vision today announced a multi-year exclusive
collaboration involving Genomic Vision's proprietary molecular combing
genomic-analysis technology.
Market News and Data brought to you by Benzinga APIs© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in